AEGLEA BIOTHERAPEUTICS INC (AGLE) Stock Price, Quote, News and Overview

What is the stock price of AEGLEA BIOTHERAPEUTICS INC today?

The current stock price of AGLE is 12.01 USD. The price increased by 8.79% in the last trading session.

What is the ticker symbol for AEGLEA BIOTHERAPEUTICS INC stock?

The exchange symbol of AEGLEA BIOTHERAPEUTICS INC is AGLE and it is listed on the Nasdaq exchange.

On which exchange is AGLE stock listed?

AGLE stock is listed on the Nasdaq exchange.

What is the price forecast or stock price prediction for AEGLEA BIOTHERAPEUTICS INC stock?

9 analysts have analysed AGLE and the average price target is 17.85 USD. This implies a price increase of 48.63% is expected in the next year compared to the current price of 12.01. Check the AEGLEA BIOTHERAPEUTICS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is AEGLEA BIOTHERAPEUTICS INC worth?

AEGLEA BIOTHERAPEUTICS INC (AGLE) has a market capitalization of 48.04M USD. This makes AGLE a Nano Cap stock.

How many employees does AEGLEA BIOTHERAPEUTICS INC have?

AEGLEA BIOTHERAPEUTICS INC (AGLE) currently has 18 employees.

What are the support and resistance levels for AEGLEA BIOTHERAPEUTICS INC (AGLE) stock?

AEGLEA BIOTHERAPEUTICS INC (AGLE) has a support level at 10.31 and a resistance level at 12.31. Check the full technical report for a detailed analysis of AGLE support and resistance levels.

Is AEGLEA BIOTHERAPEUTICS INC (AGLE) expected to grow?

The Revenue of AEGLEA BIOTHERAPEUTICS INC (AGLE) is expected to decline by -43.28% in the next year. Check the estimates tab for more information on the AGLE EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy AEGLEA BIOTHERAPEUTICS INC (AGLE) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of AGLE, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of AGLE, evaluating the profitability, health, valuation and growth aspects
• AEGLEA BIOTHERAPEUTICS INC (AGLE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• AEGLEA BIOTHERAPEUTICS INC (AGLE) Sales and EPS estimates to see what analysts future expectations are.
• AEGLEA BIOTHERAPEUTICS INC (AGLE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• AEGLEA BIOTHERAPEUTICS INC (AGLE) Insider and Institutional Ownership to learn about the owners and their transactions.
• AEGLEA BIOTHERAPEUTICS INC (AGLE) Stock Chart to make your own analysis
• AEGLEA BIOTHERAPEUTICS INC (AGLE) Latest news and press-releases to stay up to date.

Does AEGLEA BIOTHERAPEUTICS INC (AGLE) stock pay dividends?

AGLE does not pay a dividend.

When does AEGLEA BIOTHERAPEUTICS INC (AGLE) report earnings?

AEGLEA BIOTHERAPEUTICS INC (AGLE) will report earnings on 2024-03-04, after the market close.

What is the Price/Earnings (PE) ratio of AEGLEA BIOTHERAPEUTICS INC (AGLE)?

AEGLEA BIOTHERAPEUTICS INC (AGLE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-60.34).

ChartMill assigns a fundamental rating of 2 / 10 to AGLE. While AGLE seems to be doing ok healthwise, there are quite some concerns on its profitability.

Over the last trailing twelve months AGLE reported a non-GAAP Earnings per Share(EPS) of -60.34. The EPS decreased by -111.72% compared to the year before.

ChartMill assigns a Buy % Consensus number of 82% to AGLE. The Buy consensus is the average rating of analysts ratings from 9 analysts.

For the next year, analysts expect an EPS growth of 78.51% and a revenue growth -43.28% for AGLE